NCT03855956View on ClinicalTrials.gov

Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated Cirrhosis

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 27, 2019

Primary Completion Date

October 1, 2019

Study Completion Date

October 1, 2019

Conditions
Early Cirrhosis
Interventions
OTHER

KB174

KB174 is a novel mixture of oligosaccharides.

OTHER

Maltodextrin

Maltodextrin is a commercially available easily digestible polysaccharide.

Trial Locations (4)

32789

Marquez Clinical Site Partners, LLC Florida Premier Research Institute, Winter Park

33024

Research Centers of America, Hollywood

33147

Advanced Pharma CR, LLC, Miami

71201

Delta Research Partners, Monroe

Sponsors
All Listed Sponsors
lead

Kaleido Biosciences

INDUSTRY